SELECTED QUARTERLY FINANCIAL DATA
|12 Months Ended|
Dec. 31, 2019
|SELECTED QUARTERLY FINANCIAL DATA|
|SELECTED QUARTERLY FINANCIAL DATA||
14. SELECTED QUARTERLY FINANCIAL DATA
*Gross profit is computed as Net product sales less Cost of product sales. Prior to the FDA approval, manufacturing and related costs were charged to research and development expense. Therefore, these costs were not capitalized and as a result, are not fully reflected in the costs of sales during the periods disclosed above.
The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef